India’s first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has received the approval from Drug Controller General of India (DCGI). It will be utilized for active immunization against invasive disease and pneumonia caused by “Streptococcus pneumonia” among infants.
Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has been developed by Serum Institute of India Pvt Ltd, Pune. It is India’s first indigenously developed vaccine in the field of pneumonia. With the DCGI’s approval, Serum Institute of India has been granted permission to manufacture the vaccine domestically.
The Nobel Prize in Chemistry 2026 has been awarded jointly to Henri B. Kagan and…
Indian mathematician Mahesh Kakde, a professor at the Indian Institute of Science (IISc), Bengaluru, has…
India and Ghana have exchanged two Memoranda of Understanding (MoUs) to deepen cooperation in scientific…
The Ministry of Health and Family Welfare will launch JOSH (Joint Squad for Health) Teams…
Prime Minister Narendra Modi completed 25 years as the head of government on 7 October…
India has expanded its list of Classical Languages by granting the status to Marathi, Pali,…